Streetbeat News

Products Services

ABBV

Allergan Aesthetics, an AbbVie company, announced that the Journal of Cosmetic Dermatology published results from a year-long study evaluating the impact of BOTOX Cosmetic on upper facial lines in adults. The study found that 90.5% of patients were satisfied with a natural look 30 days after treatment, and this satisfaction was sustained by over 80% of patients throughout the 12-month study period.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:10 pm

XBIT

XBiotech Inc. has completed enrollment for the Phase II portion of its 1-BETTER study, a clinical study for Natrunix in combination with chemotherapy for treating pancreatic cancer. Natrunix is an antibody therapy that binds and neutralizes a substance that causes tumor growth and spread. The Phase II study enrolled 65 subjects to receive either Natrunix in combination with chemotherapy or a placebo. Key endpoints are safety and tolerability, progression-free survival, overall survival, and time-to-treatment-failure.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:08 pm

AXLA

Axcella Health Inc's stock (NASDAQ:AXLA) soared nearly 300% on Tuesday following a patent announcement for long COVID fatigue treatment, AXA1125. However, the stock pulled back on Wednesday, trading lower. Despite the recent surge, the stock is still down more than 81% over a one-year period.

Portfolio Pulse from Adam Eckert

August 30, 2023 | 1:08 pm

HOOD

Robinhood Markets Inc has added support for Bitcoin and Dogecoin to its Robinhood Wallet, and has also enabled Ethereum swaps. This move could potentially increase trading volumes on the platform.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:06 pm

DELL

Dell Technologies has partnered with Denvr Dataworks to offer cloud solutions for LLM training and inference for organizations using generative AI. This partnership aims to provide advanced AI capabilities to businesses.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 1:03 pm

BNTX

PFE

Pfizer and BioNTech have announced that their COVID-19 vaccine doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:02 pm

NAOV

NanoVibronix has reported positive outcomes from a UroShield study conducted at the University of Southampton in the U.K. This has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:01 pm

BNTX

PFE

Pfizer and BioNTech have received a positive opinion from the Committee for Medical Products for Human Use for their Omicron XBB.1.5-adapted Covid-19 vaccine in the European Union.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 1:01 pm

BUD

MAT

NVDA

A survey by investing platform Public reveals the top investment strategies for the second half of 2023, with dividend investing, artificial intelligence, and electric vehicles being the most prioritized themes. Nvidia Corporation (NASDAQ:NVDA) was highlighted as a top stock in the AI sector. Retail investors also showed increased interest in Mattel (NASDAQ:MAT) and Anheuser-Busch InBev (NYSE:BUD) due to recent news events. The survey also indicates a growing interest in using AI for investment research.

Portfolio Pulse from Chris Katje

August 30, 2023 | 1:00 pm

BA

The U.S. Federal Aviation Administration (FAA) has proposed an airworthiness directive for certain Airbus Canada A-220 airliners due to issues with electrical connectors. The directive could potentially affect the operations of airlines using these aircraft.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:57 pm